Explore the latest in atrial fibrillation, including advances in treatment and stroke prevention, recent guidelines, and long-term outcomes.
This randomized clinical trial tests the hypothesis that n-of-1 trials of self-selected atrial fibrillation triggers would enhance atrial fibrillation–related quality of life.
This cohort study uses data from the National Cardiovascular Data Registry LAAO Registry to evaluate the sex differences in the baseline characteristics of patients undergoing left atrial appendage occlusion implant and in the in-hospital outcomes after left atrial appendage occlusion implant.
This post hoc analysis of a randomized clinical trial evaluates the association between change in atrial fibrillation burden and quality of life among patients with a low preablation atrial fibrillation burden.
This case-crossover study evaluates the temporal association between episodes of atrial fibrillation and stroke in patients with cardiac implantable electronic devices.
This cohort study of individuals with early-onset atrial fibrillation examines the prevalence of disease-associated variants in susceptibility genes for inherited cardiomyopathy and arrhythmia syndromes.
This randomized clinical trial examines whether continuous cardiac rhythm monitoring enhances detection of postoperative atrial fibrillation (AF) among cardiac surgical patients during the first 30 days after hospital discharge compared with usual care.
This cohort study compares the risk of stroke and/or systemic embolism and major bleeding among patients with nonvalvular atrial fibrillation and high risk of gastrointestinal bleeding who received non–vitamin K antagonist oral anticoagulants vs warfarin.
This cross-sectional study evaluates the degree of anticoagulant use among nursing home residents with advanced dementia and atrial fibrillation at the end of life.
This cohort study examines whether the use of anticoagulation therapy is associated with the risk for stroke in individuals with atrial fibrillation aged 66 to 74 years without other CHA2DS2-VASc risk factors.
This quality improvement study assesses adherence to guideline-recommended oral anticoagulants, the temporal improvement in adherence, and the risk factors associated with oral anticoagulant prescriptions.
This cohort study uses data from the Veterans Health Administration system to compare rates of initiation of anticoagulant therapy by race/ethnicity.
This cohort study, a secondary analysis of a randomized clinical trial, assesses factors contributing to cost conversations about care plans between clinicians and patients with atrial fibrillation.
This cohort study describes comprehensive sequencing of 60 candidate atrial fibrillation genes in African American and Hispanic/Latinx probands to examine the combined prevalence of rare pathogenic variants and assess genotype-phenotype associations.
This JAMA Patient Page describes atrial fibrillation, an irregular and often rapid heart rate, and its symptoms, diagnosis, and treatment options.
Customize your JAMA Network experience by selecting one or more topics from the list below.